Control of Theileria equi, the primary cause of equine theileriosis, is largely reliant on acaracide use and chemosterilization with imidocarb dipropionate (ID). However, it is currently unknown if ID is effective against Theileria haneyi, the recently identified second causative agent of equine theileriosis, or if the drug maintains effectiveness against T. equi in the presence of T. haneyi co-infection. The purpose of this study was to address these questions using ID treatment of the following three groups of horses: (1) five T. haneyi infected horses; (2) three T. haneyi-T. equi infected horses; and (3) three T. equi-T. haneyi infected horses. Clearance was first evaluated using nPCR for each Theileria sp. on peripheral blood samples. ID failed to clear T. haneyi in all three groups of horses, and failed to clear T. equi in two of three horses in group two. For definitive confirmation of infection status, horses in groups two and three underwent splenectomy post-treatment. The T. equi-nPCR-positive horses in group two developed severe clinical signs and were euthanized. Remaining horses exhibited moderate signs consistent with T. haneyi. Our results demonstrate that ID therapy lacks efficacy against T. haneyi, and T. haneyi-T. equi co-infection may interfere with ID clearance of T. equi.
Equine piroplasmosis (EP) is an infectious, tick-borne disease caused by the hemoprotozoan parasites, Theileria equi, Babesia caballi, and a recently reported new species, T. haneyi. Infections by these apicomplexan parasites limit performance and cause economic losses for the horse industry. Equine piroplasmosis is widespread in the northern regions of Nigeria, where an increasing portion of the animal population is composed of horses. This disease has remained epidemiologically challenging, especially as the movement of horses increases across Nigeria. In this study, blood samples from 300 horses were collected in three states of northwestern Nigeria. The presence of piroplasms was screened by nested PCR targeting 18S rDNA and positive samples were analyzed using species-specific-nested PCR-targeting genes including ema1 (T. equi), rap1 (B. caballi), and a gene coding a protein of unknown function (T. haneyi). Species-specific-nPCR results demonstrated that the prevalence of T. equi was 13.0% (39/300), B. caballi was 3.3% (10/300) and T. haneyi was 2.7% (8/300). Mixed infections with T. equi and B. caballi was 2.7% (8/300) while T. equi, B. caballi, and T. haneyi multiple infection prevalence was 0.6% (2/300). We used 18S rDNA sequences to determine close relationships between T. equi by phylogenetic analysis and demonstrated that among 57 sequences of Theileria parasites, 28 samples belonged to clade A (49%), 13 samples were found to be clade C (22%), and 16 were clade D (28%). These results demonstrate the genetic diversity of T. equi circulating in horses from Nigeria.
Obesity is a state of abnormal or excessive fat accumulation. Obesity in horses increases the risk of developing a variety of health issues such as: insulin dysregulation (ID), reduced athleticism, colic, abnormal reproductive performance, laminitis, endotoxaemia, diabetes mellitus, hyperlipaemia, impaired thermoregulation, pituitary pars intermedia dysfunction, and osteochondrosis. Obesity is a significant health and welfare issue in horses that may go unreported or unnoticed due to a caregiver’s (owner) neglect. Weight gain occurs when a horse’s energy consumption exceeds his or her physical energy needs. Obesity is best assessed via necropsy or upon in vivo assessment with deuterium oxide administration, although this is not feasible in a clinical environment. In practice, obesity is assessed by: body condition scoring, cresty neck scoring, ultrasono graphic assessment, morphometric measurements, or biochemical indicators in the blood. Dietary and exercise programs are the primary means of controlling equine obesity. Pharmacologic assistance (levothyroxine sodium and metformin hydrochloride), being a secondary approach, may be effective in some cases. Management involves a long-term plan that requires the horse’s caregiver’s effort and discipline, as well as the support and supervision of their veterinarian. This paper outlines the assessment, health consequences, and management of equine obesity.
This study aimed to evaluate the effects of a supplement that contains resveratrol and hyaluronic acid (RH
supplement) in aged lame horses. A total of 16 horses of both sexes, aged between 15 and 22 years, weighing
between 350–450 kg and showing lameness due to arthritis of the knee, hock, stifle, and fetlock joints and
stiffness owing to ageing were used for the study. They comprised eight horses that were administered the RH
supplement for three weeks and eight others that served as controls and were given only a Saccharomyces
cerevisiae yeast strain used as carrier in the supplement. Blood samples were collected from each horse before
supplementation (week 0) and at weekly intervals for the three weeks of the experiment. Biochemical parameters
including creatine kinase, aspartate aminotransferase, urea, glucose, total cholesterol, sodium, potassium,
chloride, and calcium were measured by standard methods. There was a significant (P˂0.05) reduction in values
of creatine kinase and glucose in the horses administered the RH supplement. It was concluded that the RH
supplement may reduce the level of these biochemical parameters and their deleterious effects especially
during ageing in horses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.